the global Respiratory Syncytial Virus Diagnostic market was valued at USD 12.21 billion in 2018 and is expected to reach USD 21.48 billion by year 2026, at a CAGR of 7.3 %.
New York, NY -- (SBWIRE) -- 03/08/2021 -- According to the current analysis of Reports and Data, the global Respiratory Syncytial Virus Diagnostic market was valued at USD 12.21 billion in 2018 and is expected to reach USD 21.48 billion by year 2026, at a CAGR of 7.3 %. The study discusses the increased adoption of the diagnosis of respiratory syncytial virus, due to the significant increase in the number of RSV infections, with the increasing demand for molecular diagnostic tests for PoC for the diagnosis of infections. Demand for Respiratory Syncytial Virus Diagnostic is fueled by increase in demand of minimal to completely invasive testing technique, and increasing approval of RSV kits and diagnostic tests. Unpredicted climate changes as well as polluted climate has increased the incidences of pulmonary diseases such as pneumonia, bronchiolitis etc. These factors are expected to stimulate market demand for infectious disease testing such as Respiratory Syncytial Virus Diagnostic. A wide range of diagnostic tests for Respiratory Syncytial Virus are available, including molecular diagnostic tests, viral culture tests, rapid tests, serological tests and rapid immunological tests. Various players are majorly focused on combining these technologies and rapid immunoassays to develop the best approach to diagnose RSV infections. It is also anticipated that the increasing incidence of pneumonia in children will stimulate the demand for RSV testing.
Furthermore, the report is furnished with the latest impact of the COVID-19 pandemic on the market. The pandemic has affected every segment of the market, along with bringing disruption in the supply chain, demands & trends, and financial difficulties. The report covers the initial and future assessment of the COVID-19 impact on the market.
Get a FREE Report Sample with Table of Contents and Figures @ https://www.reportsanddata.com/sample-enquiry-form/2235
Further key findings from the report suggest
Immunoassay type of diagnostic technology is expected to grow at the highest CAGR of 7.8% and accounted 29.3% of the global market share in 2018
Home care end use is expected to achieve great growth in the market as the facility provide convenience and reduces the visiting fees to the hospital
According to statistics provided by WHO, about 120 million cases of pneumonia in children are expected to be diagnosed every year among that around 10% faces severe stage of childhood pneumonia.
According to the global population indicator, more than 88 billion births were reported in 2015, or about 250 births per minute. Of these, more than 2.8 million babies die in the first month due to infection and lack of detection of babies in such conditions.
According to the article published in the Journal of Pediatrics, each of the three cases of lower respiratory infection is caused by RSV, which generates an incidence rate of infection of about 30.0% in the Columbia region.
North America dominated the respiratory syncytial virus diagnosis market in 2018 accounted for 43.4% of the global respiratory syncytial virus market, due to the increasing incidence of respiratory infections and increased infant population during the prognosis period.
The diagnostic market for Respiratory Syncytial Respiratory Virus in Asia-Pacific is expected to experience the most substantial growth over the forecast period due to the high density population and the rapid rise in the prevalence of infectious diseases. China, India, Japan and Malaysia are expected to be the most dynamic markets in the region
Based on the regions, the report covers the following regions:
North America (U.S.A., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Competitive Terrain:
The global Respiratory Syncytial Virus Diagnostic market has a consolidated presence of a large number of companies that have been performing consistently to achieve optimum market growth. The report comprehensively discusses these companies' current market standing, past performances, demand & supply graphs, sales network, production & consumption patterns, and distribution channels. The report thus points out the effective business approaches undertaken by these market players to build on their market footprint.
The leading companies operating across the global Respiratory Syncytial Virus Diagnostic market are listed below:
Biomérieux, Becton-Dickinson and Company, Abbott, Roche, Danaher, Thermo Fisher, Biocartis, Luminex, Hologic, Fast Track Diagnostics.
Diagnostic Technology (Revenue, USD Million; 2018–2026)
Kits and Assays
Instruments
Others
Diagnostic Technology (Revenue, USD Million; 2018–2026)
Immunoassay
Molecular Diagnostic
Monoclonal Antibodies
Flow Cytometry
Diagnostic Imaging
Chromatography
Gel Microdroplets
Others
End Users (Revenue, USD Million; 2018–2026)
Physician Office
Hospitals
Commercial Laboratories
Nursing Homes
To get an exclusive discount on the report, visit @ https://www.reportsanddata.com/discount-enquiry-form/2235
Radical Features of the Respiratory Syncytial Virus Diagnostic Market Report:
Valuable insights into the Respiratory Syncytial Virus Diagnostic market to impart an in-depth understanding of the business verticle
An 8-year forecast estimation along with an analysis of key elements of the market
Technological advancements, regulatory framework, and recent developments covered in the report
Growth analysis and projections until 2027
Statistical analysis of the key players operating in the Respiratory Syncytial Virus Diagnostic industry
Table Of Contents:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 – 2026
Chapter 3. Indicative Metrics
3.1. Growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections
3.2. Increasing approval of RSV diagnostics
3.3. Highly dense population and unhygienic environment increases chances of RSV infection
Chapter 4. Respiratory Syncytial Virus Diagnostic Segmentation & Impact Analysis
4.1. Respiratory Syncytial Virus Diagnostic Segmentation Analysis
4.2. Respiratory Syncytial Virus Diagnostic Market Value Chain Analysis, 2018-2026
4.3. Regulatory framework
4.4. Respiratory Syncytial Virus Diagnostic Market Impact Analysis
4.4.1. Market driver analysis¬
4.4.1.1. Demand for rapid diagnostic techniques.
4.4.1.2. Increasing Burden of RSV Infections
4.4.1.3. Increasing Approval of RSV Diagnostic Kits and Assays
4.4.1.4. Increasing incidences of childhood pneumonia
4.4.2. Market restraint analysis
4.4.2.1. Low Detection Limits of Immunoassays
4.4.2.2. Shortage of specific treatment options
4.5. Key opportunities prioritized
4.6. Respiratory Syncytial Virus Diagnostic Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Respiratory Syncytial Virus Diagnostic PESTEL Analysis
Continued…
To Get This Report at a Lucrative Price, Click @ https://www.reportsanddata.com/checkout-form/2235
Thank you for reading our report. To know more about customization options, please get in touch with us. Our team will ensure the report is tailored to suit your requirements.
Have a Look at Related Reports:
Metering Pumps Market Size
Food Processing & Handling Equipments Market Share
Cloud Kitchen Market Analysis
About Reports and Data:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.